Epicutaneous Immunotherapy for Aeroallergen and Food Allergy
Epicutaneous Immunotherapy for Aeroallergen and Food Allergy
About this item
Full title
Author / Creator
Publisher
Cham: Springer International Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
Opinion statement
IgE-mediated allergies today affect up to 30 % of the population in industrialized countries. Allergen immunotherapy is the only disease-modifying treatment option with a long-term effect. However, very few patients (<5 %) choose immunotherapy, due to the long treatment duration (between 3–5 years) and possible local and system...
Alternative Titles
Full title
Epicutaneous Immunotherapy for Aeroallergen and Food Allergy
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4025904
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4025904
Other Identifiers
ISSN
2196-3053
E-ISSN
2196-3053
DOI
10.1007/s40521-013-0003-8
